United States· US:59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9

Naproxen Sodium

A naproxen product containing naproxen sodium, registered in United States by P & L Development, LLC. The same ATC class is registered in 15 of our 19 countries.

ATC M01AE02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNaproxen SodiumATCM01AE02REGISTER NO.US:59726-751_2a68267b…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Naproxen is registered in 15 of 19 countries.

Countries holding a registration under ATC M01AE02 (naproxen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Naproxen · ATC M01AE02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of naproxen costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.16 in Italy to $0.82 in Switzerland — a ×4.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Naproxen · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.82
  • IT Italy$0.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NAPROXEN SODIUM
Manufacturer
P & L Development, LLC
Country
United States (US)
ATC code
M01AE02
ATC class
Naproxen
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5972675120
    1 BOTTLE, PLASTIC in 1 BOX (59726-751-20) / 20 CAPSULE in 1 BOTTLE, PLASTIC
  • ndc11
    59726-751-20

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

495 interactions on record for naproxen.

Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Naproxen · interactions on record

495 records

  • 58 severe
  • 176 moderate
  • 17 minor
  • 161 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

83 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naproxen in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naproxen products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Aleve, Miranax
  • Belgium · Aleve, Apranax
  • Bulgaria · Налгезин, Налгезин Форте
  • Cyprus · Naprorex, Priaxen
  • Czechia · Emoxen, Nalgesin
  • Germany · Aspidolo, Dolormin Für Frauen Bei Menstruationsbeschwerden Mit
  • Denmark · Bonyl, Naproxen Evolan
  • Estonia · Emox, Nalgesin Forte
  • Spain · Actromadol, Antalgin
  • Finland · Miranax, Naprometin
  • France · Aleve, Alevetabs
  • United Kingdom (Northern Ireland) · Almus Period Pain Reliever, Boots Period Pain Reliever
  • Greece · Anaprox, Naprosyn
  • Croatia · Nalgesin, Nalgesin Forte
  • Hungary · Aleve, Aleve Extra
  • Ireland · Naprosyn Ec, Naproxen Azure Pharmaceuticals
  • Iceland · Naproxen Viatris, Naproxen-E Viatris
  • Italy · Dololibre, Femmedol
  • Lithuania · Emox, Nalgesin Forte
  • Luxembourg · Aleve, Apranax
  • Latvia · Emox, Nalgedol
  • Malta · Naprorex, Naprosyn
  • Netherlands · Aleve Classic Bij Pijn En Koorts, Aleve Feminax Bij Menstruatiepijn
  • Norway · Napren-E, Naproxen Evolan
  • Poland · 4flex Puregel, Aleve
  • Portugal · Actronadol, Ilgesin
  • Romania · Mobilat Pro, Naldorex
  • Sweden · Ipaflex, Naprocur
  • Slovenia · Nalgesin, Nalgesin Forte
  • Slovakia · Emoxen Gél, Nalgesin Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6079583f-e159-46e4-8870-03b6482dd239
GET /v1/drugs/6079583f-e159-46e4-8870-03b6482dd239?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "220",
  "substance": "NAPROXEN SODIUM",
  "productndc": "59726-751",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202807",
  "marketing_category": "ANDA"
}

See everything about naproxen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.